ESSEX INVESTMENT MANAGEMENT CO LLC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 201772 BOSTON, MA

Position in ARQT

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$3,605,250

+$214,165 QoQ

Shares Held

137,500

-4.5% QoQ

Ownership

0.109%

of shares outstanding

% of Portfolio

0.49%

of 13F equity value

Holder Rank

#86

of 271 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 51% Shared 0% None 49%

Healthcare · as of Jun 30, 2026

ESSEX INVESTMENT MANAGEMENT CO LLC holds $67,663,995 across 13 Biotechnology names. ARQT ranks #10 (5.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	43,567	$13,771,093
2	MIRM	Mirum Pharmaceuticals, Inc.	105,669	$12,370,669
3	TVTX	Travere Therapeutics, Inc.	133,866	$7,604,927
4	JAZZ	Jazz Pharmaceuticals plc	21,665	$5,220,615
5	OCUL	Ocular Therapeutix, Inc	482,154	$4,734,752
6	INSM	INSMED Inc	42,991	$4,583,700
7	PGEN	Precigen, Inc.	706,294	$4,025,875
8	AXSM	Axsome Therapeutics, Inc.	16,244	$3,976,043

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,605,250	137,500	-4.5%	Shares	Sole	2026-08-06
2026-03-31	$3,391,085	143,934	+1.9%	Shares	Sole	2026-05-11
2025-12-31	$4,102,509	141,271	-28.0%	Shares	Sole	2026-02-13
2025-09-30	$3,699,538	196,262	+3.6%	Shares	Sole	2025-11-06
2025-06-30	$2,656,944	189,511	-0.6%	Shares	Sole	2025-08-12
2025-03-31	$2,981,578	190,638	+33.5%	Shares	Sole	2025-05-07
2024-12-31	$1,989,524	142,823	-12.9%	Shares	Sole	2025-02-07
2024-09-30	$1,524,865	163,964	+0.2%	Shares	Sole	2024-10-10
2024-06-30	$1,521,117	163,561	—	Shares	Sole	2024-08-12
No filing history on record for this holder in this stock.